Avastin Market - Microvascular Complications of Diabetes, Industry insight and future trends 2022

1 / 11
About This Presentation
Title:

Avastin Market - Microvascular Complications of Diabetes, Industry insight and future trends 2022

Description:

The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). – PowerPoint PPT presentation

Number of Views:72

less

Transcript and Presenter's Notes

Title: Avastin Market - Microvascular Complications of Diabetes, Industry insight and future trends 2022


1
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to
2022byGlobalData
  • Explore all reports for Diabetes Therapeutics
    market _at_
  • http//www.rnrmarketresearch.com/reports/life-scie
    nces/pharmaceuticals/therapeutics/diabetes-therape
    utics

2
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  • The entire market for microvascular complications
    of diabetes (MCD) diabetic nephropathy,
    retinopathy, and neuropathy is facing an
    extremely high level of unmet need across the 7MM
    (US, 5EU and Japan). Despite its enormous
    potential, the MCD market is facing the major
    global barrier in the sparsely populated
    pipeline. The diabetic retinopathy segment of the
    market has recently seen rapid uptake of novel
    anti-VEGF therapies and is experiencing a strong
    growth. On the other hand, the diabetic
    neuropathy and nephropathy segments face the
    barrier in and increasing number of generic
    competitors.

Sample of the Report is available at
http//www.rnrmarketresearch.com/contacts/request-
sample?rname147160 .
3
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  • Avastin (bevacizumab) is a recombinant humanized
    IgG1 mAb that specifically binds to VEGF-A,
    thereby preventing the interaction of VEGF-A with
    its receptors on the surface of endothelial
    cells. Through VEGF-A inhibition, Avastin
    inhibits angiogenesis, and is indicated for the
    adjunctive treatment of metastatic colorectal
    cancer as well as for other types of cancer.

Sample of the Report is available at
http//www.rnrmarketresearch.com/contacts/request-
sample?rname147160 .
4
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  • Scope
  • Overview of MCD, including epidemiology,
    etiology, symptoms, diagnosis, pathology and
    treatment guidelines as well as an overview on
    the competitive landscape.
  • Detailed information on Avastin including product
    description, safety and efficacy profiles as well
    as a SWOT analysis.
  • Sales forecast for Avastin for the top seven
    countries from 2012 to 2022.
  • Sales information covered for the US, France,
    Germany, Italy, Spain, the UK and Japan.

Inquire to get Discount on the report
http//www.rnrmarketresearch.com/contacts/discoun
t?rname147160 .
5
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  • Reasons to buy
  • Understand and capitalize by identifying products
    that are most likely to ensure a robust return
  • Stay ahead of the competition by understanding
    the changing competitive landscape for MCD
  • Effectively plan your MA and partnership
    strategies by identifying drugs with the most
    promising sales potential
  • Make more informed business decisions from
    insightful and in-depth analysis of Avastin
    performance
  • Obtain sales forecast for Avastin from 2012-2022
    in top seven countries (the US, France, Germany,
    Italy, Spain, the UK and Japan)

PDF Of the Report is available at
http//www.rnrmarketresearch.com/contacts/request
-sample?rname147160 .
6
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  •  
  • Table of Contents
  •  
  • 1 Table of Contents1 Table of Contents 61.1
    List of Tables 81.2 List of Figures 8
  •  
  • 2 Introduction 92.1 Catalyst 92.2 Related
    Reports 10

Sample of the Report is available at
http//www.rnrmarketresearch.com/contacts/request-
sample?rname147160 .
7
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  • 3 Disease Overview 123.1 Etiology and
    Pathophysiology 143.1.1 Diabetic Nephropathy
    143.1.2 Diabetic Retinopathy 163.1.3 Diabetic
    Neuropathy 173.2 Prognosis 183.3 Quality of
    Life 193.4 Symptoms 20
  •  
  • 4 Disease Management 214.1 Treatment Overview
    214.1.1 Diagnosis and Referrals 214.1.2
    Screening 234.1.3 Treatment Guidelines 24

Inquire to get Discount on the report
http//www.rnrmarketresearch.com/contacts/discoun
t?rname147160 .
8
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  • 5 Competitive Assessment 325.1 Overview 325.2
    Strategic Competitor Assessment 33
  • 6 Avastin (bevacizumab) 376.1 Overview 376.2
    Efficacy 386.3 Safety 396.4 SWOT Analysis
    406.5 Forecast 41

Sample of the Report is available at
http//www.rnrmarketresearch.com/contacts/request-
sample?rname147160 .
9
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  • 7 Appendix 427.1 Bibliography 427.2
    Abbreviations 477.3 Methodology 507.4
    Forecasting Methodology 507.4.1 Diagnosed
    Patients 507.4.2 Percent Drug-Treated Patients
    517.4.3 General Pricing Assumptions 517.4.4
    Individual Drug Assumptions 527.4.5 Generic
    Erosion 527.5 Physicians and Specialists
    Included in this Study 537.6 About the Authors
    557.6.1 Analyst II - CVMD 557.6.2 Therapy
    Director - CVMD and Infectious Disease 557.6.3
    Global Head of Healthcare 567.7 About researcher
    577.8 Disclaimer 57

PDF Of the Report is available at
http//www.rnrmarketresearch.com/contacts/request
-sample?rname147160 .
10
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  • Table 1 Risk Factors for MCD 14Table 2
    Symptoms of MCD 20Table 3 Diagnostic Tests and
    Typical Criteria for MCD 22Table 4 Treatment
    Guidelines for MCD 25Table 5 Most Prescribed
    Drugs for MCD by Class in the 7MM, 2012 28Table
    6 Leading Drug Treatments for MCD, 2013 35Table
    7 Product Profile - Avastin 38Table 8 Avastin
    SWOT Analysis, 2013 40Table 9 Global Sales
    Forecasts (m) for Avastin, 2012-2022 41Table
    10 Number of High-Prescribing Physicians
    Surveyed 54
  •  
  • List of Figures
  • Figure 1 Potential Mechanisms of
    Diabetes-Induced Microvascular Complications
    13Figure 2 General Treatment Algorithms for MCD
    26
  •  
  • The report contains a list of tables and figures
    describing various market and research related to
    the industry.

Inquire to get Discount on the report
http//www.rnrmarketresearch.com/contacts/discoun
t?rname147160 .
11
Avastin (Microvascular Complications of Diabetes)
Forecast and Market Analysis to 2022
  • For more details contact Mr. Priyank Tiwari
    sales_at_rnrmarketresearch.com / 18883915441

RnR Market Research RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR  Market Research library has
syndicated reports by leading market research 
publishers across the globe.
Write a Comment
User Comments (0)